A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity From Programmed Cell Death Protein or Ligand-1 Inhibition Immunotherapy in NSCLC

Autor: Chen, Mitchell a, b, Lu, Haonan a, Copley, Susan J. a, b, Han, Yidong b, Logan, Andrew b, Viola, Patrizia c, Cortellini, Alessio a, b, Pinato, David J. a, b, d, Power, Danielle b, Aboagye, Eric O. a, ∗
Zdroj: In Journal of Thoracic Oncology June 2023 18(6):718-730
Databáze: ScienceDirect